WA

WuXi AppTec Co., Ltd.

Concentrated strategyQuality / disciplined sizingLong-term holder

Total reported value

$19.0M

Reporting period: 2024-09-30 · Number of holdings: 2

WuXi AppTec Co., Ltd. disclosed 2 holdings in its latest 13F filing for the period ending 2024-09-30, with total reported value of $19.0M and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
4
Sizing Uniformity
98.99

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1LYELLyell Immunopharma, Inc.Stock-Other53.56%-3.79%
2ADAGAdagene Inc-adrStock-Other46.44%

Holding changes this quarter

Position changes disclosed by WuXi AppTec Co., Ltd. for the quarter ending 2024-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is WuXi AppTec Co., Ltd. and what type of investor is it?
WuXi AppTec Co., Ltd. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2024-09-30), the firm manages a tracked equity portfolio valued at approximately $19.0M, spread across 2 disclosed positions.
What are WuXi AppTec Co., Ltd.'s largest equity positions?
Based on the latest 13F filing, WuXi AppTec Co., Ltd.'s top holdings by market value are: 1. Lyell Immunopharma, Inc. (LYEL) — $10.2M (53.6%) 2. Adagene Inc-adr (ADAG) — $8.8M (46.4%)
What changes did WuXi AppTec Co., Ltd. make in its most recent portfolio filing?
No notable portfolio changes were recorded for WuXi AppTec Co., Ltd. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does WuXi AppTec Co., Ltd. focus on?
Sector breakdown data is not yet available for WuXi AppTec Co., Ltd.. Check back after the next 13F processing cycle.